Extended use of sulodexide, apixaban, rivaroxaban and dabigatran in venous thromboembolism: indirect comparison of clinical trials

被引：3
|
作者：
Tomkowski, Witold [1 ]
Kuca, Pawel [1 ]
Bignamini, Angelo A. [2 ]
Andreozzi, Giseppe M. [3 ]
机构：
[1] Polish Fdn Thrombosis, Natl TB & Lung Dis Res Inst, Cardiopulm Intens Care, Warsaw, Poland
[2] Univ Milan, Sch Specializat Hosp Pharm, Dept Pharmaceut Sci, Milan, Italy
[3] Univ Hosp, Unit Angiol, Padua, Italy
来源：
INTERNATIONAL ANGIOLOGY | 2017年 / 36卷 / 05期
关键词：
ASPIRIN; PLACEBO; DISEASE;
D O I：
10.23736/S0392-9590.17.03819-6
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：496 / 497
页数：2
相关论文
共 50 条
  • [1] Indirect comparison of dabigatran, rivaroxaban, apixaban and edoxaban for the treatment of acute venous thromboembolism
    Simon Mantha
    Jack Ansell
    [J]. Journal of Thrombosis and Thrombolysis, 2015, 39 : 155 - 165
  • [2] Indirect comparison of dabigatran, rivaroxaban, apixaban and edoxaban for the treatment of acute venous thromboembolism
    Mantha, Simon
    Ansell, Jack
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2015, 39 (02) : 155 - 165
  • [3] Indirect Comparison Of Dabigatran, Rivaroxaban and Apixaban For Venous Thromboembolic Disease
    Mantha, Simon
    Ansell, Jack
    [J]. BLOOD, 2013, 122 (21)
  • [4] Dabigatran, rivaroxaban and apixaban for extended venous thromboembolism treatment: network meta-analysis
    Alotaibi, G.
    Alsaleh, K.
    Wu, C.
    McMurtry, M. S.
    [J]. INTERNATIONAL ANGIOLOGY, 2014, 33 (04) : 301 - 308
  • [5] An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation
    Mantha, Simon
    Ansell, Jack
    [J]. THROMBOSIS AND HAEMOSTASIS, 2012, 108 (03) : 476 - 484
  • [6] Dabigatran and rivaroxaban for prevention of venous thromboembolism - systematic review and adjusted indirect comparison
    Loke, Y. K.
    Kwok, C. S.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2011, 36 (01) : 111 - 124
  • [7] Indirect comparison and cost-utility of dabigatran etexilate and rivaroxaban in the treatment and extended anticoagulation of venous thromboembolism in a UK setting
    Jugrin, Anamaria Vera
    Hoesel, Volker
    Ustyugova, Anastasia
    De Francesco, Maria
    Lamotte, Mark
    Sunderland, Tom
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (01) : 1 - 10
  • [8] Management of Secondary Prevention in Venous Thromboembolism: Use of Reduced Doses of Rivaroxaban and Apixaban in Extended Therapy
    Campoy, Desiree
    Flores, Katia
    Artaza, Gonzalo
    Velasquez, Cesar A.
    Canals, Tania
    Johansson, Erik A.
    Pero, Agusti
    Sierra, Jorge
    Salinas, Ramon
    Olivera, Pavel E.
    [J]. BLOOD, 2020, 136
  • [9] Sulodexide for the extended treatment of venous thromboembolism
    Walenga, Jeanine M.
    Fareed, Jawed
    Ramacciotti, Eduardo
    [J]. INTERNATIONAL ANGIOLOGY, 2016, 35 (06) : 531 - 533
  • [10] Apixaban and Rivaroxaban in Patients With Acute Venous Thromboembolism
    Bott-Kitslaar, Dalene M.
    McBane, Robert D.
    Casanegra, Ana I.
    Houghton, Damon E.
    Froehling, David A.
    Vlazny, Danielle T.
    Ashrani, Aneel A.
    Hodge, David O.
    Vargas, Emily R.
    Bartlett, Matthew A.
    Saadiq, Rayya A.
    Daniels, Paul R.
    Shields, Raymond C.
    Lenz, Charles J.
    Lang, Teresa R.
    Wysokinski, Waldemar E.
    [J]. MAYO CLINIC PROCEEDINGS, 2019, 94 (07) : 1242 - 1252
12345